Boothbay Fund Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-147,600
Closed -$11.4M 1862
2023
Q2
$11.4M Buy
+147,600
New +$11.8M 0.25% 60
2022
Q4
Sell
-3,900
Closed -$241K 2151
2022
Q3
$241K Buy
+3,900
New +$246K 0.01% 1679
2022
Q2
Sell
-27,700
Closed -$1.65M 2400
2022
Q1
$1.65M Buy
+27,700
New +$1.77M 0.04% 660
2021
Q3
Sell
-8,600
Closed -$592K 2002
2021
Q2
$592K Buy
8,600
+8,112
+1,662% +$542K 0.02% 926
2021
Q1
$3.15M Buy
488
+167
+52% +$10.8K 0.12% 191
2020
Q4
$1.87M Buy
+321
New +$19.4K 0.07% 285
2020
Q2
Sell
-189
Closed -$1.41M 1019
2020
Q1
$1.41M Sell
189
-641
-77% -$44.3K 0.12% 221
2019
Q4
$5.39M Buy
+830
New +$54.1K 0.47% 38
2019
Q2
Sell
-150
Closed -$975K 790
2019
Q1
$975K Sell
150
-439
-75% -$29.2K 0.09% 233
2018
Q4
$3.68M Buy
589
+150
+34% +$10.5K 0.54% 38
2018
Q3
$3.39M Sell
439
-586
-57% -$44.3K 0.34% 64
2018
Q2
$7.26M Buy
+1,025
New +$72.4K 0.63% 31
2018
Q1
Sell
-850
Closed -$6.09M 751
2017
Q4
$6.09M Hold
850
0.89% 24
2017
Q3
$6.89M Sell
850
-84,150
-99% -$6.43M 1.14% 12
2017
Q2
$6.02M Buy
+85,000
New +$5.66M 1.25% 12
2016
Q4
Sell
-8,000
Closed -$633K 825
2016
Q3
$633K Buy
+8,000
New +$650K 0.14% 161
2016
Q2
Sell
-6,400
Closed -$588K 536
2016
Q1
$588K Buy
+6,400
New +$577K 0.44% 46
2015
Q3
Sell
-22,500
Closed -$2.63M 511
2015
Q2
$2.63M Buy
+22,500
New +$2.46M 1.05% 11

Other funds holding GILD

Boothbay Fund Management's GILD Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Gilead Sciences (GILD) in Q1 2026: 3,321 shares worth $463K. The stake represents 0.01% of the portfolio and ranks #1395 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in GILD as recently as Q3 2025.

Boothbay Fund Management first reported a position in GILD in Q2 2015 and has held it in 21 quarters since. The position peaked at $12.2M in Q1 2023. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Boothbay Fund Management held 3,321 shares of Gilead Sciences worth $463K as of Q1 2026.
  • Gilead Sciences was a new Boothbay Fund Management position in Q1 2026.
  • Gilead Sciences made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1395 holding.
  • Boothbay Fund Management first reported a position in Gilead Sciences in Q2 2015 and has held it in 21 quarters since.
  • Boothbay Fund Management's Gilead Sciences position peaked at $12.2M in Q1 2023.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.